Protothecosis.

Dermatol Clin

Division of Dermatology, Department of Pathology, Vanderbilt University, Dermatology 3900, The Vanderbilt Clinic, Nashville, TN 37232, USA.

Published: April 2003

Intravenous amphotericin B remains the most effective drug for eradicating Prototheca infections. It should be used as a first-line agent in cases of disseminated disease and in patients with severe underlying illness or with immunosuppression or immunocompromise. Azole antifungals and surgery should be reserved for patients with more localized disease. Itraconazole appears to be the most effective agent of this drug class, and it should be administered at 200 mg/day for 2 months. Surgical excision should be considered as a first-line therapy in patients who present with olecranon bursal infections.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0733-8635(02)00089-xDOI Listing

Publication Analysis

Top Keywords

protothecosis intravenous
4
intravenous amphotericin
4
amphotericin remains
4
remains effective
4
effective drug
4
drug eradicating
4
eradicating prototheca
4
prototheca infections
4
infections first-line
4
first-line agent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!